TY - JOUR
T1 - The clinical importance of a transcription reverse-transcription concerted (TRC) diagnosis using peritoneal lavage fluids in gastric cancer with clinical serosal invasion
T2 - A prospective, multicenter study
AU - Fujiwara, Yoshiyuki
AU - Okada, Kaoru
AU - Hanada, Hiroyuki
AU - Tamura, Shigeyuki
AU - Kimura, Yutaka
AU - Fujita, Jyunya
AU - Imamura, Hiroshi
AU - Kishi, Kentaro
AU - Yano, Masahiko
AU - Miki, Hirohumi
AU - Okada, Kazuyuki
AU - Takayama, O.
AU - Aoki, Taro
AU - Mori, Masaki
AU - Doki, Yuichiro
PY - 2014/3
Y1 - 2014/3
N2 - Purpose We have developed a novel molecular method of diagnosis using the technique of transcriptase-reverse transcriptase concerted reaction (TRC) for the detection of cancer micrometastasis. This study prospectively examined the clinical importance of the TRC diagnosis with peritoneal lavage fluids collected from gastric cancer operations at multiple institutes. Methods TRC amplification targeting carcinoembryonic antigen mRNA was applied to detect gastric cancer cells in peritoneal lavage fluids obtained during gastric cancer resections from nine different hospitals. A total of 137 patients with a clinical diagnosis of serosa-invading neoplasms were enrolled to investigate the correlation between the TRC diagnosis and patient prognosis. Results Of the 137 patients, 27 (20%) were positive by cytologic examination. In contrast, TRC targeting carcinoembryonic antigen mRNA was positive in 59 of 137 (54%) patients. TRC positivity was associated with a poorer overall survival in all patients and in the 104 patients who underwent a curative operation. TRC positivity also was associated with the peritoneal recurrence-free survival rate in the 104 curative cases. Multivariate analysis showed that TRC positivity and the pathologic N factor were prognostic factors for the overall survival time. Conclusion Our prospective multicenter study showed that the TRC test using peritoneal lavage fluids could be a potential prognostic factor to predict patient survival and peritoneal recurrence with clinically diagnosed, serosa-invading gastric cancer.
AB - Purpose We have developed a novel molecular method of diagnosis using the technique of transcriptase-reverse transcriptase concerted reaction (TRC) for the detection of cancer micrometastasis. This study prospectively examined the clinical importance of the TRC diagnosis with peritoneal lavage fluids collected from gastric cancer operations at multiple institutes. Methods TRC amplification targeting carcinoembryonic antigen mRNA was applied to detect gastric cancer cells in peritoneal lavage fluids obtained during gastric cancer resections from nine different hospitals. A total of 137 patients with a clinical diagnosis of serosa-invading neoplasms were enrolled to investigate the correlation between the TRC diagnosis and patient prognosis. Results Of the 137 patients, 27 (20%) were positive by cytologic examination. In contrast, TRC targeting carcinoembryonic antigen mRNA was positive in 59 of 137 (54%) patients. TRC positivity was associated with a poorer overall survival in all patients and in the 104 patients who underwent a curative operation. TRC positivity also was associated with the peritoneal recurrence-free survival rate in the 104 curative cases. Multivariate analysis showed that TRC positivity and the pathologic N factor were prognostic factors for the overall survival time. Conclusion Our prospective multicenter study showed that the TRC test using peritoneal lavage fluids could be a potential prognostic factor to predict patient survival and peritoneal recurrence with clinically diagnosed, serosa-invading gastric cancer.
UR - http://www.scopus.com/inward/record.url?scp=84894024649&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894024649&partnerID=8YFLogxK
U2 - 10.1016/j.surg.2013.10.004
DO - 10.1016/j.surg.2013.10.004
M3 - Article
C2 - 24439740
AN - SCOPUS:84894024649
VL - 155
SP - 417
EP - 423
JO - Surgery
JF - Surgery
SN - 0039-6060
IS - 3
ER -
